VOYA Investment Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Sell |
48,364
-47,060
| -49% | -$545K | ﹤0.01% | 1840 |
|
|
2025
Q1 | $833K | Buy |
95,424
+18,635
| +24% | +$163K | ﹤0.01% | 1645 |
|
|
2024
Q4 | $1.1M | Buy |
76,789
+4,943
| +7% | +$71K | ﹤0.01% | 1543 |
|
|
2024
Q3 | $1.62M | Sell |
71,846
-6,004
| -8% | -$136K | ﹤0.01% | 1411 |
|
|
2024
Q2 | $1.51M | Sell |
77,850
-336,395
| -81% | -$6.54M | ﹤0.01% | 1416 |
|
|
2024
Q1 | $15.5M | Buy |
414,245
+353,687
| +584% | +$13.3M | 0.02% | 616 |
|
|
2023
Q4 | $3.39M | Buy |
60,558
+19,250
| +47% | +$1.08M | ﹤0.01% | 1150 |
|
|
2023
Q3 | $1.7M | Sell |
41,308
-1,355
| -3% | -$55.9K | ﹤0.01% | 1394 |
|
|
2023
Q2 | $2.38M | Buy |
42,663
+8,235
| +24% | +$460K | ﹤0.01% | 1285 |
|
|
2023
Q1 | $1.92M | Sell |
34,428
-985
| -3% | -$55K | ﹤0.01% | 1370 |
|
|
2022
Q4 | $1.29M | Buy |
35,413
+3
| +0% | +$109 | ﹤0.01% | 1522 |
|
|
2022
Q3 | $1.01M | Sell |
35,410
-394
| -1% | -$11.2K | ﹤0.01% | 1627 |
|
|
2022
Q2 | $1.62M | Sell |
35,804
-5,298
| -13% | -$240K | ﹤0.01% | 1194 |
|
|
2022
Q1 | $3.13M | Sell |
41,102
-4,370
| -10% | -$332K | 0.01% | 979 |
|
|
2021
Q4 | $6.77M | Buy |
45,472
+17,062
| +60% | +$2.54M | 0.01% | 735 |
|
|
2021
Q3 | $4.14M | Sell |
28,410
-60,198
| -68% | -$8.76M | 0.01% | 909 |
|
|
2021
Q2 | $17.4M | Buy |
88,608
+7,904
| +10% | +$1.55M | 0.03% | 396 |
|
|
2021
Q1 | $14.6M | Buy |
80,704
+58,412
| +262% | +$10.6M | 0.03% | 443 |
|
|
2020
Q4 | $3.16M | Buy |
22,292
+991
| +5% | +$140K | 0.01% | 966 |
|
|
2020
Q3 | $2.66M | Buy |
21,301
+308
| +1% | +$38.4K | 0.01% | 931 |
|
|
2020
Q2 | $1.88M | Buy |
+20,993
| New | +$1.88M | ﹤0.01% | 1043 |
|